H-L-Lys(Boc)-OAll*HCl

H-L-Lys(Boc)-OAll*HCl is a protected lysine derivative presented as the hydrochloride salt, combining an N-Boc-protected α-amino group with an OAll* (allyl-type) ester at the carboxyl position while retaining the stereodefined L-lysine backbone. The molecule contains the ε-amino side chain of lysine, which is typically present in a protected or salt-stabilized form under the provided hydrochloride conditions, enabling controlled chemoselective transformations. The Boc carbamate and the allyl ester functionality provide orthogonal protection modes that support stepwise peptide building block preparation, including acid-stable handling and selective deprotection strategies. The presence of a chiral center at the α-carbon and a protected carboxyl group makes the compound suitable for downstream amino acid coupling chemistries and for generating well-defined lysine-containing intermediates for peptide and peptidomimetic synthesis.

1. Peptide Synthesis

H-L-Lys(Boc)-OAll*HCl is applied in peptide synthesis workflows where lysine incorporation requires orthogonal protection of the α-amino and carboxyl functionalities. The Boc-protected amino group and the allyl-type ester at the carboxyl position support controlled peptide coupling and subsequent deprotection sequences that preserve the stereochemistry of the L-lysine residue. The hydrochloride salt form can facilitate handling and conversion to activated coupling partners under standard amino acid derivative chemistries while maintaining compatibility with common peptide coupling strategies. The resulting lysine-containing building blocks enable preparation of protected peptide fragments and longer sequences for research-grade peptide libraries and structure-activity relationship studies. The protected lysine architecture also supports C-terminal and side-chain functionalization steps that follow peptide assembly.

2. Side-Chain Functionalization

H-L-Lys(Boc)-OAll*HCl serves as a platform for lysine side-chain modification in chemical biology and synthetic organic chemistry, leveraging the ε-amino functionality of lysine for targeted derivatization. The Boc group protects the α-amino site during side-chain chemistry, while the allyl-type ester can be managed to control chemoselectivity between carboxyl activation and side-chain transformations. The hydrochloride salt state helps define protonation behavior of the basic amino groups, which can be relevant for controlled conjugation conditions and for reproducible downstream functional group installation. Lysine derivatives prepared from this scaffold can be converted into amide, urea, sulfonamide, or other nitrogen-linked motifs that are frequently required for peptide analogs, affinity tags, and labeling reagents. The stereodefined lysine backbone ensures that modified derivatives remain consistent with peptide-like recognition patterns in subsequent studies.

3. Protected Amino Acid Chemistry

H-L-Lys(Boc)-OAll*HCl is utilized as a protected amino acid intermediate for manufacturing-oriented fine chemical synthesis where orthogonal protecting-group logic is required. The Boc carbamate provides acid-stable protection for the α-amino group, while the OAll* ester offers a handle for controlled deprotection or transformation distinct from Boc removal. The defined salt form supports formulation and intermediate handling considerations during multi-step synthesis, including isolation of crystalline intermediates and reproducible conversion to coupling-ready forms. The compound can be employed to generate lysine building blocks with a protected N-terminus and a carboxyl functionality that can be activated or converted into peptide coupling derivatives. Downstream synthetic utility extends to scalable preparation of protected lysine-containing fragments used in peptide manufacturing and in the synthesis of peptidomimetic scaffolds.

4. Bioconjugation Chemistry

H-L-Lys(Boc)-OAll*HCl is relevant to bioconjugation and biomolecule modification strategies that require lysine-reactive functionality while maintaining controlled protection of other amino acid sites. The protected α-amino group reduces undesired crosslinking during conjugation steps, while the lysine side-chain amino group can be converted into conjugation-ready intermediates that participate in amide-forming, carbamate-forming, or other nitrogen-directed coupling chemistries. The allyl-type ester and Boc group can be managed to tune the order of deprotection and activation, enabling preparation of conjugates with defined termini and reduced heterogeneity. The stereochemical integrity of the L-lysine residue supports consistent incorporation into peptide-based linkers and labeling constructs used in biochemical research. The hydrochloride salt character can also influence solubility and handling during synthesis of conjugation reagents and linker molecules.

5. Pharmaceutical Manufacturing

H-L-Lys(Boc)-OAll*HCl is suitable for pharmaceutical manufacturing and process chemistry contexts that require reliable protected amino acid feedstocks for peptide and peptidomimetic intermediate production. The Boc-protected α-amino group and the orthogonally managed OAll* carboxyl protection are compatible with stepwise assembly routes that generate protected peptide segments and subsequent deprotection schedules. The lysine backbone provides a predictable functional handle for downstream coupling, side-chain derivatization, and formation of defined amide or protected nitrogen linkages in larger synthetic sequences. The hydrochloride salt form supports practical intermediate handling and conversion to activated derivatives within multi-step manufacturing operations. The compound's role as a chiral amino acid intermediate aligns with industrial needs for stereochemically consistent building blocks used to construct complex peptide-like molecules.

1. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L

2. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides

3. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

4. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

5. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries